Search Options Stock News and Analysis from Schaeffer's

Patent Lawsuit Loss Sends AMRN Stock Spiraling

https://www.schaeffersresearch.com/content/news/2020/03/31/patent-lawsuit-loss-sends-amrn-stock-spiraling

3/31/2020 10:37 AM

On the charts, things are looking pretty bleak for Amarin Corporation plc (NASDAQ:AMRN) right now. The equity is down 68.4% at $4.29 during its first hour of trading -- on pace for its worst day in o...

Amarin Calls Pop After Big FDA Ruling

https://www.schaeffersresearch.com/content/news/2019/12/16/amarin-calls-pop-after-big-fda-ruling

12/16/2019 10:12 AM

The shares of Amarin Corporation (NASDAQ:AMRN) are up 1.9% to trade at $24.57, after the Food and Drug Administration (FDA) approved Vascepa -- the drugmaker's fish-oil derived treatment for heart di...

Dow Futures Under Pressure From Renewed Trade Tensions

https://www.schaeffersresearch.com/content/ezines/2019/08/09/dow-futures-under-pressure-from-renewed-trade-tensions

8/9/2019 9:24 AM

Dow Jones Industrial Average (DJI) futures are signaling a triple-digit drop this morning, as the blue-chip index looks unable to build on yesterday's strong gains. Trade tensions with China resu...

Jefferies Moves In Quickly on Amarin's Vascepa Setback

https://www.schaeffersresearch.com/content/news/2019/08/09/jefferies-moves-in-quickly-on-amarins-vascepa-setback

8/9/2019 9:19 AM

Amarin Corporation plc (NASDAQ:AMRN) is one of the biggest losers before the bell today, last seen with pre-market losses of 19.2% to trade at $14.39. A label expansion application for the company's ...

Upbeat Vascepa Expectations Boost Amarin Stock

https://www.schaeffersresearch.com/content/news/2019/07/02/upbeat-vascepa-expectations-boost-amarin-stock

7/2/2019 9:37 AM

Amarin Corporation plc (NASDAQ:AMRN) stock is trading up 6.8% at $20.55 this morning, after the cardiovascular disease specialist said it expects 2019 revenue to arrive between $380 million and $420 m...

PEOPLE ALSO SEARCH FOR